Nipro Corporation (TYO:8086)

Japan flag Japan · Delayed Price · Currency is JPY
1,257.50
-31.00 (-2.41%)
May 22, 2025, 3:30 PM JST
5.27%
Market Cap 210.15B
Revenue (ttm) 644.59B
Net Income (ttm) 5.11B
Shares Out 163.10M
EPS (ttm) 27.78
PE Ratio 46.38
Forward PE 16.50
Dividend 32.00 (2.46%)
Ex-Dividend Date Mar 28, 2025
Volume 712,400
Average Volume 554,685
Open 1,271.00
Previous Close 1,288.50
Day's Range 1,252.50 - 1,278.00
52-Week Range 1,170.00 - 1,505.50
Beta 0.03
RSI 46.66
Earnings Date May 12, 2025

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ products, functional products, dialysis products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products. This business also operates dialysis and training centers. The company’s Pharmaceutical-Related bu... [Read more]

Sector Healthcare
Founded 1947
Employees 38,117
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 8086
Full Company Profile

Financial Performance

In 2024, Nipro's revenue was 644.59 billion, an increase of 9.85% compared to the previous year's 586.79 billion. Earnings were 5.11 billion, a decrease of -53.97%.

Financial Statements

News

There is no news available yet.